Showing results (51-60 of 157) with videos related to
Sort By:
Pageof 16
Future Medicinal Chemistry|August 28, 2015
Pirinixic acids: flexible fatty acid mimetics with various biological activitiesDaniel Merk, Martina Zettl, Dieter Steinhilber, et al.Journal of Medicinal Chemistry|January 23, 2026
Click. Screen. Degrade. A Miniaturized D2B Workflow for Rapid PROTAC DiscoveryMarko Mitrović, Francesco Aleksy Greco, Yiliam Cruz García, et al.Chemistryopen|October 30, 2019
Synthetic Activators of Cell Migration Designed by Constructive Machine LearningDominique Bruns, Daniel Merk, Karthiga Santhana Kumar, et al.Pharmacology & Therapeutics|December 3, 2015
Small molecules with anti-inflammatory properties in clinical developmentThomas Hanke, Daniel Merk, Dieter Steinhilber, et al.Chemmedchem|February 8, 2022
Scaffold Hopping from Amodiaquine to Novel Nurr1 Agonist Chemotypes via Microscale Analogue LibrariesSabine Willems, Marcel Müller, Julia Ohrndorf, et al.International Journal of Molecular Sciences|October 29, 2020
Chemical Starting Matter for HNF4α Ligand Discovery and ChemogenomicsIsabelle Meijer, Sabine Willems, Xiaomin Ni, et al.Chemmedchem|May 30, 2019
Computer-Assisted Selective Optimization of Side-Activities-from Cinalukast to a PPARα ModulatorJulius Pollinger, Simone Schierle, Sebastian Neumann, et al.ACS Pharmacology & Translational Science|April 16, 2021
Differential Therapeutic Effects of FXR Activation, sEH Inhibition, and Dual FXR/sEH Modulation in NASH in Diet-Induced Obese MiceMoritz Helmstädter, Jurema Schmidt, Astrid Kaiser, et al.ACS Medicinal Chemistry Letters|January 8, 2026
Dual Nurr1/RXR agonism of valerenic acid and synthetic mimetics enables dimer-selective Nurr1 modulationKatharina Scholz, Úrsula López-García, Romy Busch, et al.Nature Communications|April 11, 2026
Structural optimization of drug molecules with incrementally trained language modelsTim Hörmann, Domenic Mayer, Max Lewandowski, et al.Pageof 16